MedTrace Logo

Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season

NCT06603090 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66147

Last updated 2025-07-11

No results posted yet for this study

Summary

This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.

Conditions

Interventions

BEHAVIORAL

Text message influenza vaccine reminders

Text message influenza vaccine reminders

BEHAVIORAL

Text message COVID-19 vaccine reminders

Text message COVID-19 vaccine reminders

BEHAVIORAL

Text message influenza and COVID-19 vaccine reminders

Text message influenza and COVID-19 vaccine reminders

Sponsors & Collaborators

Principal Investigators

  • Melissa Stockwell, MD MPH · Columbia University

  • Alex Fiks, MD MSCE · Children's Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-02
Primary Completion
2024-12-31
Completion
2025-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06603090 on ClinicalTrials.gov